Considering that he's worth an estimated $5.7 billion, entrepreneur and investor Mark Cuban probably doesn't have a lot of ...

Cuban has taken issue with Meta CEO Mark Zuckerberg and his proposal to work closely with President-elect Donald Trump ...

"There's nobody who looks at the healthcare system or the pharmaceutical industry and says ‘wow, that’s well run.'" ...

At the Fortune Brainstorm Tech Dinner in Las Vegas, Fortune's Andrew Nusca interviews Mark Cuban about his work with Cost Plus Drugs. Cuban discusses disrupting the pharmaceutical industry, tackling ...

Plus Oceans Healthcare adds five states with acquisition and UTA professor leads $1.8 million study.

Mark Cuban has a reputation as a dependable and trustworthy investor among the ‘Shark Tank’ participants.

Cuban didn't immediately embrace the flashy lifestyle many associate with newfound wealth. He lived modestly, buying "the ...

Legislative efforts are underway to regulate PBMs more effectively, with bipartisan support emerging in Congress. Additionally, new market entrants like Mark Cuban's Cost Plus Drugs are challenging ...

As criticism of pharmacy benefit managers heats up, fear of lawsuits is driving some big employers to drop the “Big Three” ...

Ann Lewandowski knows all about pharmacy benefit managers, or PBMs, the companies that shape the U.S. drug market. Her job, ...

Interactive Brokers has shown strong performance in 2024 with a 113.5% year-to-date gain, including a 27% increase this ...